Posted 03 September 2013
By John Driscoll
Understanding the US Food and Drug Administration (FDA) requirements for prescription drug promotion begins with knowledge of the agency's requirements for prescription drug labeling. Specifically, the Full Prescribing Information (PI), the comprehensive piece of FDA-approved labeling that provides the regulatory boundaries for the promotion of a prescription drug, is the focus of this chapter from John Driscoll's new book, FDA Requirements for Prescription Drug Promotion.
Share this article:
Categories: Labeling, US, FDA
Tags: label, advertising, promotion